Holen Sie sich die Stockscreener-App
63.41
0.52%
-0.33
Handel nachbörslich:
63.00
-0.41
-0.65%
Schlusskurs vom Vortag:
$63.74
Offen:
$64.19
24-Stunden-Volumen:
2.81M
Relative Volume:
0.51
Marktkapitalisierung:
$31.31B
Einnahmen:
$198.10B
Nettoeinkommen (Verlust:
$-6.45B
KGV:
-4.8241
EPS:
-13.1443
Netto-Cashflow:
$7.11B
1W Leistung:
-4.56%
1M Leistung:
+0.70%
6M Leistung:
+37.58%
1J Leistung:
+136.96%
1-Tages-Spanne:
$62.97
$64.60
1-Wochen-Bereich:
$62.86
$67.64
52-Wochen-Spanne:
$25.07
$69.36
Centene Corp Stock (CNC) Company Profile
Firmenname
Centene Corp
Sektor
Branche
Telefon
(314) 725-4477
Adresse
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
63.41 | 31.31B | 198.10B | -6.45B | 7.11B | -13.14 |
UNH
Unitedhealth Group Inc
|
420.74 | 382.09B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
107.74 | 137.47B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
377.68 | 81.91B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
289.57 | 76.60B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
389.32 | 46.74B | 137.20B | 1.15B | 1.27B | 9.3439 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-07-28 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-07-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-02 | Herabstufung | UBS | Buy → Neutral |
| 2025-06-09 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-04-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-02-06 | Herabstufung | Argus | Buy → Hold |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-10 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-03-21 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Eingeleitet | Argus | Buy |
| 2022-08-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Fortgesetzt | Barclays | Overweight |
| 2022-07-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-21 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Fortgesetzt | Bernstein | Outperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-07 | Fortgesetzt | Barclays | Overweight |
| 2022-01-06 | Fortgesetzt | JP Morgan | Overweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-13 | Bestätigt | BofA Securities | Buy |
| 2021-12-13 | Bestätigt | Credit Suisse | Neutral |
| 2021-12-13 | Bestätigt | Mizuho | Neutral |
| 2021-12-13 | Bestätigt | Oppenheimer | Outperform |
| 2021-12-13 | Bestätigt | Stephens | Overweight |
| 2021-12-13 | Bestätigt | Truist | Buy |
| 2021-12-13 | Bestätigt | Wells Fargo | Overweight |
| 2021-12-13 | Bestätigt | Wolfe Research | Outperform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Eingeleitet | Mizuho | Neutral |
| 2021-01-21 | Fortgesetzt | Goldman | Neutral |
| 2021-01-15 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-01-28 | Bestätigt | Bernstein | Outperform |
| 2020-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-10-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Fortgesetzt | Citigroup | Neutral |
| 2017-12-18 | Bestätigt | Jefferies | Buy |
| 2017-09-13 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2017-02-08 | Bestätigt | Barclays | Overweight |
| 2017-02-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Centene Corp Aktie (CNC) Neueste Nachrichten
Centene stock remains anchored by Medicaid scale and earnings - AD HOC NEWS
Ex-Centene VP claims company used records access as pretext to replace her with younger hire - The Business Journals
Centene stock trades with earnings pressure and Medicaid shifts - AD HOC NEWS
Is Centene Corp (CNC) a Bargain After 3.3% Drop? GF Value Says U - GuruFocus
Centene Corp. stock underperforms Thursday when compared to competitors - MarketWatch
10 Health Care Stocks With Whale Alerts In Today’s Session - Benzinga
Centene (CNC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance
CNC|Centene Corp|Price:63.740| - TradingKey
Centene Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Centene accused of age discrimination by ousted VP - STLtoday.com
Is Centene Stock a Smart Buy Ahead of Q2 Earnings? Key Estimates - Yahoo Finance
Centene stock reflects managed care earnings power as Medicaid shift continues - AD HOC NEWS
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Centene stock trades steady as Medicaid membership returns to growth - AD HOC NEWS
Cognizant Lands Centene Mega Deal Worth Over $500 Mn: Report - analyticsindiamag.com
Cognizant Wins Multi-Year Centene Deal That Could Touch $1 Billion - outlookbusiness.com
Cognizant bags over $500 million Centene deal, deepens AI push in healthcare - Storyboard18
Cognizant bags mega deal from Centene, likely worth over $500 million - Moneycontrol.com
Smart Money Is Buying Centene Corp. (CNC) - The Acquirer's Multiple
Centene (NYSE: CNC) grants 3,155 restricted stock units to director Tyler - Stock Titan
Centene stock trades steady as Medicaid and marketplace growth shapes 2026 outlook - AD HOC NEWS
Centene stock trades steady as Medicaid and marketplace membership support recent earnings momentum - AD HOC NEWS
Centene stock reflects its latest earnings and market backdrop. - Ad-hoc-news.de
Centene Corp (CNC) Shares Surge 4.0% -- What GF Score of 73 Tells Investors - GuruFocus
Centene Corporation’s Stock Price Soars to $66.44, Marking a Robust 3.99% Increase - Smartkarma
Why Centene (CNC) Stock Is Up Today - Quiver Quantitative
Centene stock holds near health insurance peers after latest earnings - ad-hoc-news.de
Centene Beats 401(k) Suit Over Collective Trusts, Forfeitures - Bloomberg Law News
Arkansas Explained: What’s happening to the state’s Medicaid expansion? - Arkansas Advocate
Lobbying Update: $30,000 of CENTENE CORPORATIONS lobbying was just disclosed - Quiver Quantitative
Centene (CNC) Stock Sees Modest Fair Value Lift As Analysts Back Earnings Recovery - Yahoo Finance
What's Behind Centene's Recent Stock Plunge - Kavout | AI
Is Centene Corp (CNC) a Bargain After 3.1% Drop? GF Value Says U - GuruFocus
Why is Centene stock sliding today? - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
Centene stock holds steady as managed care strategy targets Medicaid and marketplace growth - Ad-hoc-news.de
Publicly held genetic testing firm sues Centene, alleging prenatal test reimbursement scheme - The Business Journals
Centene Corp stock hits 52-week high at 69.35 USD By Investing.com - Investing.com South Africa
Centene Stock Soars 66% YTD: Should Investors Chase the Rally? - Yahoo Finance
CNC Maintained by TD Cowen -- Price Target Raised to $65 - GuruFocus
Centene Corp stock hits 52-week high at 69.35 USD - Investing.com
Centene Corporation (CNC) Rallied Following the Robust Result - Yahoo Finance
CNC Maintained by Wells Fargo -- Price Target Raised to $69.00 - GuruFocus
Centene stock reflects steady managed care positioning amid US healthcare policy shifts - ad-hoc-news.de
Centene (CNC) Stock May Still Be A Bargain After A 114% Run - Yahoo Finance
Daily Brief Health Care: Centene Corp, FibroBiologics, Molina Healthcare, Solvonis Therapeutics and more - Smartkarma
Centene (CNC) Joins Growth Indexes On A Narrative That May Already Be Priced In - Yahoo Finance
Centene Corporation to release Q2FY26 results on July 28 - scanx.trade
Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth? - Yahoo Finance
Centene stock reflects a diversified health insurance model in a complex US care landscape - Ad Hoc News
CNC Maintained by RBC Capital -- Price Target Raised to $71.00 - GuruFocus
Finanzdaten der Centene Corp-Aktie (CNC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.44%
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):